As of 1:00pm ET
| +0.01 / +0.66%|
The 6 analysts offering 12-month price forecasts for Cardiome Pharma Corp have a median target of 5.45, with a high estimate of 9.50 and a low estimate of 2.20. The median estimate represents a +256.21% increase from the last price of 1.53.
The current consensus among 6 polled investment analysts is to Buy stock in Cardiome Pharma Corp. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.